MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx

IRVINE, Calif. and HERSTAL, Belgium, March 18, 2019 /PRNewswire/ — MDxHealth SA (Euronext: MDXH.BR) today announces that positive data from a pre-biopsy clinical validation and optimization study of SelectMDx® were presented at the 34th Annual European Association of Urology (EAU)…

Source: https://www.prnewswire.com:443/news-releases/mdxhealth-announces-positive-data-from-pan-european-clinical-validation-study-of-selectmdx-300813658.html